{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "SARS-CoV-2",
      "Sofia",
      "rapid antigen"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33239376",
  "DateCompleted": {
    "Year": "2021",
    "Month": "01",
    "Day": "27"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "05",
    "Day": "29"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "01",
        "Day": "21"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "e02727-20",
      "10.1128/JCM.02727-20"
    ],
    "Journal": {
      "ISSN": "1098-660X",
      "JournalIssue": {
        "Volume": "59",
        "Issue": "2",
        "PubDate": {
          "Year": "2021",
          "Month": "Jan",
          "Day": "21"
        }
      },
      "Title": "Journal of clinical microbiology",
      "ISOAbbreviation": "J Clin Microbiol"
    },
    "ArticleTitle": "Comparison of the Quidel Sofia SARS FIA Test to the Hologic Aptima SARS-CoV-2 TMA Test for Diagnosis of COVID-19 in Symptomatic Outpatients.",
    "Abstract": {
      "AbstractText": [
        "The Quidel Sofia severe acute respiratory syndrome (SARS) fluorescent immunoassay (FIA) test (SOFIA) is a rapid antigen immunoassay for the detection of SARS coronavirus 2 (SARS-CoV-2) proteins from nasal or nasopharyngeal swab specimens. The purpose of this study was to compare the results of the SOFIA test to those of the Hologic Aptima SARS-CoV-2 TMA test (APTIMA TMA), a high-throughput molecular diagnostic test that uses transcription-mediated amplification (TMA) for the detection of SARS-CoV-2 nucleic acid from upper respiratory tract specimens. Three hundred forty-seven symptomatic patients from an urgent care center in an area with a high prevalence of SARS-CoV-2 infections were tested in parallel using nasal swabs for the SOFIA test and nasopharyngeal swabs for the APTIMA TMA test. The SOFIA test demonstrated a positive percent agreement (PPA) of 82.0% with the APTIMA TMA test for symptomatic patients tested\u2009\u22645\u2009days from symptom onset and a PPA of 54.5% for symptomatic patients\u2009>5\u2009days from symptom onset. The Cepheid Xpert Xpress SARS-CoV-2 reverse transcription-PCR (RT-PCR) test was used to determine the cycle threshold (<i>C<sub>T</sub></i> ) value for any specimens that were discrepant between the SOFIA and APTIMA TMA tests. Using a <i>C<sub>T</sub></i> value of\u2009\u226435 as a surrogate for SARS-CoV-2 culture positivity, we estimate that the SOFIA test detected 87.2% of symptomatic patients tested\u2009\u22645\u2009days from symptom onset who were likely to be culture positive."
      ],
      "CopyrightInformation": "Copyright \u00a9 2021 American Society for Microbiology."
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-3383-8665"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology, ACL Laboratories, West Allis, Wisconsin, USA eric.beck@aah.org."
          },
          {
            "Identifier": [],
            "Affiliation": "Advocate Aurora Health, Milwaukee, Wisconsin, USA."
          }
        ],
        "LastName": "Beck",
        "ForeName": "Eric T",
        "Initials": "ET"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology, ACL Laboratories, West Allis, Wisconsin, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Advocate Aurora Health, Milwaukee, Wisconsin, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Aurora West Bend Clinic, West Bend, Wisconsin, USA."
          }
        ],
        "LastName": "Paar",
        "ForeName": "Wendy",
        "Initials": "W"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Advocate Aurora Health, Milwaukee, Wisconsin, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Urgent Care, Primary Care Service Line, Aurora Health Care Medical Group, Milwaukee, Wisconsin, USA."
          }
        ],
        "LastName": "Fojut",
        "ForeName": "Lara",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Advocate Aurora Health, Milwaukee, Wisconsin, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Aurora West Bend Clinic, West Bend, Wisconsin, USA."
          }
        ],
        "LastName": "Serwe",
        "ForeName": "Jordan",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Advocate Aurora Health, Milwaukee, Wisconsin, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Urgent Care, Primary Care Service Line, Aurora Health Care Medical Group, Milwaukee, Wisconsin, USA."
          }
        ],
        "LastName": "Jahnke",
        "ForeName": "Renee R",
        "Initials": "RR"
      }
    ],
    "PublicationTypeList": [
      "Comparative Study",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Clin Microbiol",
    "NlmUniqueID": "7505564",
    "ISSNLinking": "0095-1137"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antigens, Viral"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged, 80 and over"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Ambulatory Care Facilities"
    },
    {
      "QualifierName": [
        "analysis"
      ],
      "DescriptorName": "Antigens, Viral"
    },
    {
      "QualifierName": [
        "diagnosis",
        "pathology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "COVID-19 Testing"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child, Preschool"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Diagnostic Tests, Routine"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Fluoroimmunoassay"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infant"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Molecular Diagnostic Techniques"
    },
    {
      "QualifierName": [
        "virology"
      ],
      "DescriptorName": "Nasopharynx"
    },
    {
      "QualifierName": [
        "genetics",
        "immunology",
        "isolation & purification"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Sensitivity and Specificity"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Young Adult"
    }
  ]
}